This document summarizes information about different drugs used to treat convulsive disorders like epilepsy. It discusses several commonly used anti-epileptic drugs including carbamazepine, clonazepam, gabapentin, lamotrigine, phenytoin, and vigabatrin. For each drug, it provides brief details on how the drug works, common dosages, potential side effects, and other relevant information. The overall document aims to educate about effective pharmaceutical options for controlling seizures and convulsive disorders.
Amitriptyline 25mg film coated tablets smpc- taj pharmaceuticalsTaj Pharma
Amitriptyline Dosage & Rx Info | Amitriptyline Uses, Side Effects -: Indications, Side Effects, Warnings, Amitriptyline - Drug Information - Taj Pharma, Amitriptyline dose Taj pharmaceuticals Amitriptyline interactions, Taj Pharmaceutical Amitriptyline contraindications, Amitriptyline price, Amitriptyline Taj Pharma Amitriptyline 25mg Film-Coated Tablets SMPC- Taj Pharma . Stay connected to all updated on Amitriptyline Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Amitriptyline 25mg film coated tablets smpc- taj pharmaceuticalsTaj Pharma
Amitriptyline Dosage & Rx Info | Amitriptyline Uses, Side Effects -: Indications, Side Effects, Warnings, Amitriptyline - Drug Information - Taj Pharma, Amitriptyline dose Taj pharmaceuticals Amitriptyline interactions, Taj Pharmaceutical Amitriptyline contraindications, Amitriptyline price, Amitriptyline Taj Pharma Amitriptyline 25mg Film-Coated Tablets SMPC- Taj Pharma . Stay connected to all updated on Amitriptyline Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
learning objective includes : pathogenesis,clinical features, classification of migraine, pharmacology about specific antimigraine drugs, coverage to newer triptan- Lasmiditan and newer prophylactic drug Erenumab a CGRP receptor antagonist.
by: Dr. Vishal Pawar, MD Pharmacology
All the recent updates regarding antiepileptics, composed into a single ppt presentation to make researching and learning easier
learning objective includes : pathogenesis,clinical features, classification of migraine, pharmacology about specific antimigraine drugs, coverage to newer triptan- Lasmiditan and newer prophylactic drug Erenumab a CGRP receptor antagonist.
by: Dr. Vishal Pawar, MD Pharmacology
All the recent updates regarding antiepileptics, composed into a single ppt presentation to make researching and learning easier
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.Dr. Kiran Dhamak
Central Nervous System is one of the unit in Pharmacotherapeutics Subject which is for Second Year Diploma in Pharmacy. The unit covers diseases like Epilepsy, Parkinson, Alzheimer, Stroke and Migraine. The presentation includes the point as per diploma in pharmacy students may understand very easily. The syllabus is framed by Pharmacy Council of India which is implemented by MSBTE ER 2020-2021
Epilepsy is a brain condition that causes repeated, sudden, brief changes in the brain's electrical activity. These changes cause various types of symptoms.
Depression is a mental disorder and has become most common in recent years. This slide or presentation deals with all types of aetiologies of depression, theories that are involved in development of depression, pathophysiology of drepression, various classes anti-depressant their pharmacology with the adverse events or effects. This also gives a brief note on difference between depression and sadness.
the causes, pathophysiology, clinical manifestations, diagnosis and treatment of epilepsy has been discussed in detail with the perspective of a subject called pathophysiology in both medical sciences as well as the pharmaceutical sciences
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
1. Drug effective in convulsive
disorder
By:
Dr. Mohan Kumar
LECTURE No.1
2. Convulsive disorder (Epilepsy)
• Epilepsy is a central nervous system (neurological) disorder in which
brain activity becomes abnormal, causing seizures or periods of
unusual behavior, sensations, and sometimes loss of awareness.
• Anyone can develop epilepsy. Epilepsy affects both males and
females of all races, ethnic backgrounds and ages.
• Seizure symptoms can vary widely.
• Some people with epilepsy simply stare blankly for a few seconds
during a seizure, while others repeatedly twitch their arms or legs.
• Having a single seizure doesn't mean you have epilepsy. At least
two unprovoked seizures are generally required for an epilepsy
diagnosis.
• Treatment with medications or sometimes surgery can control
seizures for the majority of people with epilepsy. Some people
require lifelong treatment to control seizures, but for others, the
seizures eventually go away. Some children with epilepsy may
outgrow the condition with age.
3. Seizure
• A seizure is usually defined as a sudden alteration of behavior due
to a temporary change in the electrical functioning of the brain.
• Normally, the brain continuously generates tiny electrical impulses
in an orderly pattern.
• These impulses travel along neurons — the network of nerve cells
in the brain — and throughout the whole body via chemical
messengers called neurotransmitters.
• In epilepsy the brain's electrical rhythms have a tendency to
become imbalanced, resulting in recurrent seizures.
• In patients with seizures, the normal electrical pattern is disrupted
by sudden and synchronized bursts of electrical energy that may
briefly affect their consciousness, movements or sensations.
4. Symptoms
• Epilepsy is caused by abnormal activity in the brain, seizures can
affect any process your brain coordinates and the Seizure signs and
symptoms may include:-
• Temporary confusion
• A staring spell
• Uncontrollable jerking movements of the arms and legs
• Loss of consciousness or awareness
• Psychic symptoms such as fear, anxiety
• Symptoms vary depending on the type of seizure. In most cases, a
person with epilepsy will tend to have the same type of seizure
each time, so the symptoms will be similar from episode to
episode.
• Doctors generally classify seizures as either focal or generalized,
based on how the abnormal brain activity begins.
5. Anti-epileptic drug
• Antiepileptic drugs are medicines that reduce
the frequency of epileptic seizures.
• This class of drugs includes some drugs that
have other uses as well. Phenobarbital is a
barbiturate.
6. Different drugs used are:-
• Carbamazepine
• Clonazepam
• Gabapentin
• Lamotrigine
• Phenytoin
• Vigabatrin
7. Carbamazepine
• carbamazepine (Tegretol, Carbatrol): A favorite partial
seizure medicine in the developed world.
Carbamazepine affects sodium channels, and inhibits
rapid firing of brain cells.
• Long-acting forms such as Carbatrol or Tegretol-XR can
be given once a day.
• Potential side effects include GI upset, weight gain,
blurred vision, low blood counts, low blood sodium
(hyponatremia).
• Carbamazepine causes a rash rate of a few percent,
sometimes even the dangerous rash called Stevens-
Johnson syndrome. People of Asian descent with HLA-
B*1502 antigen are more at risk. Typical adult dose is
400 mg tid
8. Clonazepam
• clonazepam (Klonopin): Clonazepam is a member of the
drug class known as benzodiazepines, to which diazepam
(Valium), lorazepam (Ativan), clorazepate (Tranxene),
alprazolam (Xanax) also belong.
• Benzodiazepines are used as anti-seizure drugs, sedatives,
tranquilizers and muscle relaxants. Benzodiazepines
increase the effectiveness of GABA, the brain’s main
inhibitory neurotransmitter.
• Clonazepam is more long-acting against seizures than are
diazepam or lorazepam.
• Side effects of clonazepam include sedation,
thinking/memory impairment, mood changes, addiction.
More so than most, its effects wear off over time.
• A typical adult dose is 0.5-1.0 mg three times a day.
9. Gabapentin
• gabapentin (Neurontin): Gabapentin has the
reputation of being a safe but not particularly powerful
AED. The effectiveness criticism probably is because it
is often prescribed at too low a dose.
• The drug probably works by influencing transport of
GABA and effects on calcium channels.
• It has no drug interactions, is not metabolized in the
liver and it does not bind to blood proteins. Side effects
are unsteadiness, weight gain, fatigue, dizziness.
• Typical adult dose is 300-600 mg three times a, but
doses can be up to 1200 mg three times a day.
10. Lamotrigine
• lamotrigine (Lamictal): A broad-spectrum alternative to
VPA, with a better side effect profile. However, LTG may not
be as effective for myoclonic seizures.
• Lamotrigine works by several mechanisms including
blocking release of glutamate, the brain’s main excitatory
neurotransmitter.
• It has the usual side effects of dizziness and fatigue, usually
mild cognitive (thinking) impairment. Severe medical side
effects are unusual. The practical side effect issue is rash,
occurring in several percent of people who take it,
especially if the dose is increased too fast.
• Therefore, it takes a couple of months to get up to the
typical adult dose of 200 mg twice a day.
11. Phenytoin
• phenytoin (Dilantin):
• Phenytoin alters brain cell sodium channels, which has the effect of
limiting rapid firing of the brain cells.
• It is inexpensive.
• Common side effects are unsteadiness and moderate cognitive
problems.
• There are long-term potential cosmetic (body/face hair growth, skin
problems), and bone problems (osteoporosis).
• Phenytoin causes a rash rate of a few percent, sometimes even the
dangerous rash called Stevens-Johnson syndrome.
• Typical adult dose is 300-400 mg per day, usually with 100 mg pills.
Phenytoin can be started quickly in an emergency with intravenous
administration, or a large dose of capsules if an immediate effect is
required. Small changes in phenytoin dose can cause large changes
in serum drug levels, so the blood levels can be hard to regulate.
The target serum level is 10-20 mcg per ml
12. Vigabatrin
• vigabatrin (Sabril):
• Vigabatrin is a “designer drug,” made to block
metabolism of GABA, the brain’s main
inhibitory neurotransmitter.
• Regular vision testing is recommended for all
people on this drug. A typical regimen begins
with 500 mg twice a day, and can increase
over a month or two to 1500 mg twice a day